Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
5-day change
1st Jan Change
2,007
JPY
-0.89%
+3.72%
+17.44%
Eiken Chemical Co., Ltd. Revises Consolidated and Non Consolidated Financial Forecast for the Fiscal Year Ending March 31, 2017
Eiken Chemical Co., Ltd. revised of the consolidated financial forecast for the fiscal year ending March 31, 2017. For the fiscal year ending March 31, 2017, the company revised Net sales of JPY 33,190 against JPY 33,830 Previous forecasted. Operating income of JPY 4,000 against JPY 2,710 Previous forecasted. Ordinary income of JPY 4,140 against JPY 2,710 Previous forecasted. Net income attributable to shareholders of parent company of JPY 2,770 against JPY 1,820 Previous forecasted. Net income per share JPY 15.25 against JPY 99.47 Previous forecasted.
For the fiscal year ending March 31, 2017, the company revised non-consolidated net sales of JPY 33,160 against JPY 33,670 Previous forecasted. Operating income of JPY 4,100 against JPY 2,720 Previous forecasted. Ordinary income of JPY 4,220 against JPY 4,220 Previous forecasted. Net income attributable to shareholders of parent company of JPY 2,850 against JPY 1,820 Previous forecasted. Net income per share JPY 155.62 against JPY 99.47 Previous forecasted.
Tranche Update on Eiken Chemical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.
Mar. 21
CI
Eiken Chemical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 2,500,000 shares, representing 6.74% for ¥4,636.95 million.
Mar. 18
CI
Eiken Chemical Co., Ltd. announces an Equity Buyback for 2,700,000 shares, representing 7.28% for ¥5,400 million.
Jan. 30
CI
Eiken Chemical Co., Ltd. authorizes a Buyback Plan.
Jan. 29
CI
Lucira Health, Inc. Provides Notice of Termination of the Patent License Agreement by and Between the Company and Eiken Chemical Co., Ltd
22-03-14
CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2020
19-07-23
CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2019
19-01-28
CI
Medicinal Genomics Corp. Partners with Eiken Chemical Co., Ltd. for Cannabis Testing to Drive Higher Yield
19-01-03
CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2019
18-04-26
CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018
18-01-25
CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Announces Dividend for the Six Months Ended September 30, 2017, Payable on December 1, 2017; Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2018
17-10-23
CI
Eiken Chemical Co., Ltd. Revised Consolidated and Non Consolidated Earnings Guidance for the First Six Months of Fiscal Year Ending September 30, 2017
17-09-13
CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the First Half Year of Fiscal 2018 and Full Year Ending March 2018
17-07-25
CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Consolidated and Non-Consolidated Earnings Guidance for the Fiscal First Half of 2018 and Full Year of 2018; Declares Consolidated Dividend for the Year Ended March 31, 2017, Payable on June 5, 2017; Provides Dividend Guidance for the Fiscal First Half of 2018 and Full Year of 2018
17-04-26
CI
Eiken Chemical Co., Ltd. Revises Consolidated and Non Consolidated Financial Forecast for the Fiscal Year Ending March 31, 2017
17-03-13
CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2016; Provides Earnings and Dividend Guidance for the Full Year Ending March 31, 2017
17-01-25
CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2016; Declares Interim Dividend for the Six Months Ended September 30, 2016, Payable on December 1, 2016; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2017; Provides Earnings Guidance for the Fiscal Full Year Ending March 31, 2017
16-10-24
CI
Meridian Bioscience, Inc. Expands Molecular Test Technology License with Eiken Chemical Co., Ltd
16-09-26
CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Consolidated Earnings Guidance for the First Six Months and for the Full Year for the Year Ending March 31, 2017; Provides Interim and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2017
16-07-25
CI
Eiken Chemical Co., Ltd. Reports Consolidated and Parent Earnings Results for the Year Ended Mar. 30, 2016; Provides Consolidated and Parent Earnings and Dividend Guidance for the Six Months and Full Year of Fiscal 2017
16-04-26
CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2015; Provides Consolidated Earnings Results for the Fiscal Year Ending March 31, 2016; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2016
16-01-25
CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2015; Declares Quarterly Dividend, Payable on December 01, 2015; Provides Dividend Guidance for the Fourth Quarter and Full Year Ending March 31, 2016; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2016
15-10-22
CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015 Provides Second Quarter and Year End Dividend Guidance for Full Year of the Fiscal Year Ending March 31, 2016; Provides Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2016
15-07-23
CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Full Year Ended March 31, 2015; Provides Consolidated and Non- Consolidated Earnings Guidance for the First Half of Fiscal Year Ending March 31, 2016 and Full Year Ending March 31, 2016; Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2016 and Full Year Ending March 31, 2016; Announces Dividend for the Year Ended March 31, 2015, Payable on June 4, 2015
15-04-26
CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Ending March 31, 2015
15-01-26
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
EIKEN CHEMICAL CO., LTD. is a Japan-based company principally engaged in the manufacture and sale of test drugs. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
More about the company
Last Close Price
2,007
JPY
Average target price
1,750
JPY
Spread / Average Target
-12.81%
Consensus
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
EIKEN CHEMICAL CO., LTD. 
